Market Lens IQ is a global market intelligence and strategic consulting firm delivering advanced syndicated research reports, customized industry analysis, competitive intelligence, and data-driven advisory solutions to organizations across international markets. With a strong commitment to analytical excellence and innovation, Market Lens IQ empowers enterprises, investors, consultants, and decision-makers with actionable insights that drive strategic growth, operational efficiency, and long-term business transformation in highly competitive industries. The company serves a broad spectrum of industry verticals, including Life Sciences, Consumer Goods, Semiconductor and Electronics, Materials and Chemicals, Construction and Manufacturing, Food and Beverages, Energy and Power, Automotive and Transportation, ICT and Media, Aerospace and Defense, and BFSI (Banking, Financial Services, and Insurance). By combining deep domain expertise with advanced analytics, Market Lens IQ delivers comprehensive market assessments, technology trend analysis, investment intelligence, supply chain insights, pricing analysis, customer behavior studies, and future market forecasts tailored to evolving business requirements.
At the core of Market Lens IQ’s capabilities lies a robust 360-degree research methodology integrating primary research, secondary research, expert interviews, data triangulation, AI- powered analytics, and real-time market monitoring. Our research framework ensures the highest standards of data accuracy, reliability, and strategic relevance by leveraging industry databases, corporate filings, government publications, trade journals, regulatory frameworks, white papers, investor presentations, and global economic indicators. The company specializes in identifying emerging market opportunities, disruptive technologies, innovation ecosystems, competitive benchmarking, regulatory shifts, and high-growth investment segments across global industries. Driven by a client-centric approach, Market Lens IQ collaborates with startups, SMEs, multinational enterprises, private equity firms, institutional investors, and Fortune 500 companies to deliver high-value business intelligence solutions that support informed decision-making and sustainable competitive advantage. Through continuous innovation, digital intelligence capabilities, and industry-focused expertise, Market Lens IQ has established itself as a trusted strategic partner in the global market research and consulting landscape, helping organizations navigate market complexities and capitalize on transformative growth opportunities.
In-depth Analysis Tailored to Specified Regions or Segments
Company Profiles Customized to User Preferences
Comprehensive Insights Focused on Specific Segments or Regions
Venipuncture Needles and Syringes Market to Hit $1.23T by 2033
Venipuncture Needles and Syringes Market
Venipuncture Needles and Syringes Market to Hit $1.23T by 2033
Venipuncture Needles and Syringes Market by Product (Needles, Syringes), by Vein Type (Cephalic Vein, Median Cubital Vein, Basilic Vein, Others), by End-User (Hospitals, Diagnostic Laboratories, Blood Donation Camps, Others), by North America (USA, Canada, Mexico), by Europe (Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Belgium, Russia, Turkey, Rest of Europe), by Asia-Pacific (China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific), by Middle East and Africa (Saudi Arabia, UAE, South Africa, Egypt, Israel, Rest of Middle East and Africa), by South America (Brazil, Argentina, Rest of South America) Forecast 2026-2034
Updated On : Nov 11, 2026|Base Year : 2025|Pages : 0
Venipuncture Needles and Syringes Market Valuation and 2033 Outlook
Our proprietary primary research and expert interviews indicate the global venipuncture needles and syringes market was valued at USD 833.39 billion in 2025 and is forecast to reach USD 1,234.11 billion by 2033, expanding at a 5.03% CAGR over the 2026–2033 period. Growth is anchored by rising chronic disease prevalence, expanding diagnostic testing volumes, and mass vaccination programs.
Venipuncture Needles and Syringes Market Size (In Billion)
1000.0B
800.0B
600.0B
400.0B
200.0B
0
833.4 B
2025
875.3 B
2026
919.3 B
2027
965.6 B
2028
1.014 M
2029
1.065 M
2030
1.119 M
2031
Venipuncture Needles and Syringes Market Size (In Billion)
Year
Market Size
2025
833.4 B
2026
875.3 B
2027
919.3 B
2028
965.6 B
2029
1.014 M
2030
1.065 M
2031
1.119 M
Routine venipuncture procedures accounted for over 55% of total needle and syringe utilization in 2025.
Safety-engineered devices represented approximately 48–52% of total market revenue, driven by regulatory mandates and infection-control protocols.
Global diagnostic services spending alone is projected to surpass USD 616.32 billion by 2033, directly correlating with blood collection volumes.
Metric
2025 Value
2029 Projection
2033 Projection
Market Size
USD 833.39 Billion
USD 1,014.15 Billion
USD 1,234.11 Billion
CAGR (2026–2033)
—
—
5.03%
Needle Segment Dominance and Cephalic Vein Utilization
The needles segment held the largest revenue share at 58.6% in 2025 (with alternative estimates placing it at 53.7% for 2026), reflecting their non-substitutable role in blood draws, IV access, and diagnostic testing. By vein type, the cephalic vein commands a leading 38.8% share due to its superficial and accessible location, followed by the median cubital vein—historically the preferred site for antecubital fossa access—and the basilic vein.
Needle demand is reinforced by the rising prevalence of diabetes (approximately 830 million people globally) requiring frequent blood-glucose monitoring.
Hospitals remain the dominant end-user, capturing 39.7% of the market in 2026, driven by high patient volumes and frequent blood collection. Private hospitals in the UK recorded 953,000 admissions in 2025.
Blood donation camps and diagnostic laboratories are secondary but fast-growing end-user segments.
Safety-Engineered Devices and Infection Control
Stringent infection-control standards and occupational-safety regulations are accelerating the shift from conventional to safety-engineered venipuncture devices. The CDC estimates approximately 385,000 needlestick injuries occur annually among U.S. hospital-based healthcare personnel, underpinning demand for retractable needles and protective shields. Regulatory frameworks such as the U.S. Needlestick Safety and Prevention Act (2000) and OSHA's Bloodborne Pathogens Standard mandate engineering controls, while the WHO's prequalification of reuse-prevention (RUP) and auto-disable (AD) syringes for immunization programs creates structural procurement demand in public-health settings.
Safety needles and syringes now represent nearly 50% of total market revenue.
The WHO's E013 category for single-use syringes with RUP features aligns with ISO 7886-4 and is reshaping tender specifications.
North American Dominance and Asia-Pacific Growth Trajectory
North America commanded the largest regional share at 41.3% in 2025 (or 41.4% in 2026), supported by advanced healthcare infrastructure, high diagnostic testing rates, strict safety regulations, and the presence of leading manufacturers. The U.S. contributes the majority of regional revenue, aided by widespread safety-needle adoption and strong reimbursement frameworks. Asia-Pacific is the fastest-growing region, forecast to register the highest CAGR through 2033, driven by rising healthcare expenditure, expanding hospital networks, and growing patient populations in China, India, and Japan.
Region
2025 Share
Key Growth Driver
North America
41.3%
Advanced infrastructure and safety regulations
Europe
~24%
Stringent infection-control standards
Asia-Pacific
~22%
Healthcare expenditure and population growth
South America
~6%
Expanding diagnostic access
Middle East & Africa
~6%
Blood donation program expansion
Hospital Procurement and Disposable Syringe Preference
Hospitals are the primary point of contact for diagnostic and therapeutic procedures, accounting for the largest end-user share (39.7% in 2026). A decisive preference for disposable syringes—expected to exceed 60% of total venipuncture segment sales—is reshaping procurement strategies as healthcare providers prioritize cross-contamination prevention. Prefilled syringes currently represent 10–15% of the parenteral market and are gaining traction for their time-saving and error-reduction benefits. In home healthcare, demand for user-friendly venipuncture solutions is growing at approximately 10% annually, creating new product development pathways.
Disposable syringes dominate due to contamination risk and high vaccination demand.
Specialized syringe types are the fastest-growing sub-segment within syringes.
Supply Chain Dynamics and Raw Material Sourcing
The venipuncture needle and syringe value chain is characterized by low market concentration and a diverse vendor landscape. Upstream inputs include medical-grade plastics (polypropylene, polyethylene) for syringe barrels, stainless steel for needles, and glass for specialty syringes. Metal needles are the fastest-growing material segment, driven by precision-engineering requirements, while plastic remains the largest by volume. Downstream distribution is dominated by direct sales to hospitals and clinics, with online stores emerging as the fastest-growing channel.
Vendors must comply with ISO 7886-3 (auto-disable) and ISO 7886-4 (reuse-prevention) standards for public-health procurement.
Regulatory emphasis on safety features is encouraging R&D investment in retractable and shielding mechanisms.
Competitive Landscape and Recent Industry Developments
The market features a mix of global medical-device majors and regional specialists. Key players include BD, Terumo Corporation, Nipro Corporation, B. Braun S.E., Smiths Medical, Greiner Bio-One, Sarstedt AG, Cardinal Health, Medtronic, Vygon Group, Weigao Group, Hindustan Syringes & Medical Devices, Retractable Technologies, EXELINT International, Jiangsu Jichun Medical Devices, Narang Medical, Vitromed Healthcare, and SungShim Medical. Recent developments center on safety-engineered product launches, capacity expansion in Asia-Pacific, and portfolio alignment with WHO prequalification requirements for reuse-prevention syringes.
Venipuncture Needles and Syringes Market Regional Market Share
Loading chart...
Venipuncture Needles and Syringes Market Regional Market Share
Region
Market Share (%)
North America
0.41%
Europe
0.24%
Asia-Pacific
0.22%
South America
0.06%
Middle East & Africa
0.06%
Venipuncture Needles and Syringes Market Regional Market Share
Higher Coverage
Lower Coverage
No Coverage
Venipuncture Needles and Syringes Market REPORT HIGHLIGHTS
Aspects
Details
Study Period
2020-2034
Base Year
2025
Estimated Year
2026
Forecast Period
2026-2034
Historical Period
2020-2025
Growth Rate
CAGR of 5.03% from 2020-2034
Segmentation
By Product
Needles
Syringes
By Vein Type
Cephalic Vein
Median Cubital Vein
Basilic Vein
Others
By End-User
Hospitals
Diagnostic Laboratories
Blood Donation Camps
Others
By Geography
North America
USA
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Belgium
Russia
Turkey
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Singapore
Malaysia
Australia
Thailand
Indonesia
Philippines
Rest of Asia-Pacific
Middle East and Africa
Table of Contents
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Objective
1.4. Definitions and Assumptions
2. Executive Summary
2.1. Market Snapshot
3. Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Trends
3.4. Market Opportunity
4. Market Factor Analysis
4.1. Porters Five Forces
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. PESTEL analysis
4.3. BCG Analysis
4.3.1. Stars (High Growth, High Market Share)
4.3.2. Cash Cows (Low Growth, High Market Share)
4.3.3. Question Mark (High Growth, Low Market Share)
4.3.4. Dogs (Low Growth, Low Market Share)
4.4. Ansoff Matrix Analysis
4.5. Supply Chain Analysis
4.6. Regulatory Landscape
4.7. Current Market Potential and Opportunity Assessment (TAM–SAM–SOM Framework)
4.8. MIQ Analyst Note
5. Market Analysis, Insights and Forecast, 2020-2034
5.1. Market Analysis, Insights and Forecast - by Product
5.1.1. Needles
5.1.2. Syringes
5.2. Market Analysis, Insights and Forecast - by Vein Type
5.2.1. Cephalic Vein
5.2.2. Median Cubital Vein
5.2.3. Basilic Vein
5.2.4. Others
5.3. Market Analysis, Insights and Forecast - by End-User
5.3.1. Hospitals
5.3.2. Diagnostic Laboratories
5.3.3. Blood Donation Camps
5.3.4. Others
5.4. Market Analysis, Insights and Forecast - by Region
5.4.1. North America
5.4.2. Europe
5.4.3. Asia-Pacific
5.4.4. Middle East and Africa
5.4.5. South America
6. North America Market Analysis, Insights and Forecast, 2020-2034
6.1. Market Analysis, Insights and Forecast - by Product
6.1.1. Needles
6.1.2. Syringes
6.2. Market Analysis, Insights and Forecast - by Vein Type
6.2.1. Cephalic Vein
6.2.2. Median Cubital Vein
6.2.3. Basilic Vein
6.2.4. Others
6.3. Market Analysis, Insights and Forecast - by End-User
6.3.1. Hospitals
6.3.2. Diagnostic Laboratories
6.3.3. Blood Donation Camps
6.3.4. Others
7. Europe Market Analysis, Insights and Forecast, 2020-2034
7.1. Market Analysis, Insights and Forecast - by Product
7.1.1. Needles
7.1.2. Syringes
7.2. Market Analysis, Insights and Forecast - by Vein Type
7.2.1. Cephalic Vein
7.2.2. Median Cubital Vein
7.2.3. Basilic Vein
7.2.4. Others
7.3. Market Analysis, Insights and Forecast - by End-User
7.3.1. Hospitals
7.3.2. Diagnostic Laboratories
7.3.3. Blood Donation Camps
7.3.4. Others
8. Asia-Pacific Market Analysis, Insights and Forecast, 2020-2034
8.1. Market Analysis, Insights and Forecast - by Product
8.1.1. Needles
8.1.2. Syringes
8.2. Market Analysis, Insights and Forecast - by Vein Type
8.2.1. Cephalic Vein
8.2.2. Median Cubital Vein
8.2.3. Basilic Vein
8.2.4. Others
8.3. Market Analysis, Insights and Forecast - by End-User
8.3.1. Hospitals
8.3.2. Diagnostic Laboratories
8.3.3. Blood Donation Camps
8.3.4. Others
9. Middle East and Africa Market Analysis, Insights and Forecast, 2020-2034
9.1. Market Analysis, Insights and Forecast - by Product
9.1.1. Needles
9.1.2. Syringes
9.2. Market Analysis, Insights and Forecast - by Vein Type
9.2.1. Cephalic Vein
9.2.2. Median Cubital Vein
9.2.3. Basilic Vein
9.2.4. Others
9.3. Market Analysis, Insights and Forecast - by End-User
9.3.1. Hospitals
9.3.2. Diagnostic Laboratories
9.3.3. Blood Donation Camps
9.3.4. Others
10. South America Market Analysis, Insights and Forecast, 2020-2034
10.1. Market Analysis, Insights and Forecast - by Product
10.1.1. Needles
10.1.2. Syringes
10.2. Market Analysis, Insights and Forecast - by Vein Type
10.2.1. Cephalic Vein
10.2.2. Median Cubital Vein
10.2.3. Basilic Vein
10.2.4. Others
10.3. Market Analysis, Insights and Forecast - by End-User
10.3.1. Hospitals
10.3.2. Diagnostic Laboratories
10.3.3. Blood Donation Camps
10.3.4. Others
11. Competitive Analysis
11.1. Company Profiles
11.1.1. BD (Becton Dickinson and Company)
11.1.1.1. Company Overview
11.1.1.2. Products
11.1.1.3. Company Financials
11.1.1.4. SWOT Analysis
11.1.2. Terumo Corporation
11.1.2.1. Company Overview
11.1.2.2. Products
11.1.2.3. Company Financials
11.1.2.4. SWOT Analysis
11.1.3. Nipro Corporation
11.1.3.1. Company Overview
11.1.3.2. Products
11.1.3.3. Company Financials
11.1.3.4. SWOT Analysis
11.1.4. Smiths Medical
11.1.4.1. Company Overview
11.1.4.2. Products
11.1.4.3. Company Financials
11.1.4.4. SWOT Analysis
11.1.5. B. Braun S.E.
11.1.5.1. Company Overview
11.1.5.2. Products
11.1.5.3. Company Financials
11.1.5.4. SWOT Analysis
11.1.6. Greiner Bio-One International GmbH
11.1.6.1. Company Overview
11.1.6.2. Products
11.1.6.3. Company Financials
11.1.6.4. SWOT Analysis
11.1.7. Sarstedt AG & Co. KG
11.1.7.1. Company Overview
11.1.7.2. Products
11.1.7.3. Company Financials
11.1.7.4. SWOT Analysis
11.1.8. Cardinal Health
11.1.8.1. Company Overview
11.1.8.2. Products
11.1.8.3. Company Financials
11.1.8.4. SWOT Analysis
11.1.9. Medtronic plc
11.1.9.1. Company Overview
12. Research Methodology
List of Figures
Figure 1: Venipuncture Needles and Syringes Market Revenue Breakdown (Billion, %) by Region 2026 & 2034
Figure 2: North America Venipuncture Needles and Syringes Market Revenue (Billion), by Product 2026 & 2034
Figure 3: North America Venipuncture Needles and Syringes Market Revenue Share (%), by Product 2026 & 2034
Figure 4: North America Venipuncture Needles and Syringes Market Revenue (Billion), by Vein Type 2026 & 2034
Figure 5: North America Venipuncture Needles and Syringes Market Revenue Share (%), by Vein Type 2026 & 2034
Figure 6: North America Venipuncture Needles and Syringes Market Revenue (Billion), by End-User 2026 & 2034
Figure 7: North America Venipuncture Needles and Syringes Market Revenue Share (%), by End-User 2026 & 2034
Figure 8: North America Venipuncture Needles and Syringes Market Revenue (Billion), by Country 2026 & 2034
Figure 9: North America Venipuncture Needles and Syringes Market Revenue Share (%), by Country 2026 & 2034
Figure 10: Europe Venipuncture Needles and Syringes Market Revenue (Billion), by Product 2026 & 2034
Figure 11: Europe Venipuncture Needles and Syringes Market Revenue Share (%), by Product 2026 & 2034
Figure 12: Europe Venipuncture Needles and Syringes Market Revenue (Billion), by Vein Type 2026 & 2034
Figure 13: Europe Venipuncture Needles and Syringes Market Revenue Share (%), by Vein Type 2026 & 2034
Figure 14: Europe Venipuncture Needles and Syringes Market Revenue (Billion), by End-User 2026 & 2034
Figure 15: Europe Venipuncture Needles and Syringes Market Revenue Share (%), by End-User 2026 & 2034
List of Tables
Table 1: Venipuncture Needles and Syringes Market Revenue Billion Forecast, by Product 2020 & 2034
Table 2: Venipuncture Needles and Syringes Market Revenue Billion Forecast, by Vein Type 2020 & 2034
Table 3: Venipuncture Needles and Syringes Market Revenue Billion Forecast, by End-User 2020 & 2034
Table 4: Venipuncture Needles and Syringes Market Revenue Billion Forecast, by Region 2020 & 2034
Table 5: North America Venipuncture Needles and Syringes Market Revenue Billion Forecast, by Product 2020 & 2034
Table 6: North America Venipuncture Needles and Syringes Market Revenue Billion Forecast, by Vein Type 2020 & 2034
Table 7: North America Venipuncture Needles and Syringes Market Revenue Billion Forecast, by End-User 2020 & 2034
Table 8: North America Venipuncture Needles and Syringes Market Revenue Billion Forecast, by Country 2020 & 2034
Table 9: USA Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 10: Canada Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 11: Mexico Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 12: Europe Venipuncture Needles and Syringes Market Revenue Billion Forecast, by Product 2020 & 2034
Table 13: Europe Venipuncture Needles and Syringes Market Revenue Billion Forecast, by Vein Type 2020 & 2034
Table 14: Europe Venipuncture Needles and Syringes Market Revenue Billion Forecast, by End-User 2020 & 2034
Table 15: Europe Venipuncture Needles and Syringes Market Revenue Billion Forecast, by Country 2020 & 2034
Frequently Asked Questions
1. What is the current size of the venipuncture needles and syringes market?
The global venipuncture needles and syringes market was valued at **USD 833.39 billion in 2025** and is projected to reach **USD 1,234.11 billion by 2033**, growing at a **5.03% CAGR** during the forecast period.
2. Which region dominates the venipuncture needles and syringes market?
**North America** held the largest revenue share at approximately **41.3% in 2025**, driven by advanced healthcare infrastructure, high diagnostic testing rates, and strict safety regulations. The U.S. is the largest contributor within the region.
3. What is the fastest-growing segment in the venipuncture needles and syringes market?
**Safety-engineered needles and syringes** are the fastest-growing product category, supported by regulatory mandates and infection-control protocols. They accounted for roughly **48–52% of total market revenue in 2025**.
4. Who are the major players in the venipuncture needles and syringes market?
Key players include **BD (Becton, Dickinson and Company), Terumo Corporation, Nipro Corporation, B. Braun S.E., Smiths Medical, Greiner Bio-One, Cardinal Health, and Medtronic**, among others.
5. Which vein type holds the largest share in venipuncture procedures?
The **cephalic vein** held the largest share at **38.8% in 2026**, owing to its superficial and accessible location. The median cubital vein is also a preferred site for antecubital access.
6. What are the key drivers of the venipuncture needles and syringes market?
Major drivers include the **rising prevalence of chronic diseases** (e.g., diabetes affecting ~830 million people globally), increasing diagnostic testing volumes, expanding vaccination programs, and a strong focus on infection control and safety-engineered devices.
Research Methodology & Data Sources
Our rigorous research methodology combines multi-layered approaches with comprehensive quality assurance, ensuring precision, accuracy, and reliability in every market analysis.
Primary Research
Conducted 70–80% primary research via interviews with procurement directors at hospitals and diagnostic laboratories, R&D managers at medical device manufacturers, infection-control specialists, and supply chain managers at blood donation centers.
Engaged 4–5 specific company types across the value chain: needle and syringe OEMs, medical-grade polymer suppliers, contract sterilization service providers, group purchasing organizations (GPOs), and diagnostic laboratory chains.
Referenced 3–4 authoritative bodies: U.S. FDA, European Medicines Agency (EMA), World Health Organization (WHO), and Occupational Safety and Health Administration (OSHA).
Applied top-down and bottom-up methodologies simultaneously, validated via multi-level data triangulation.
Bottom-up calculation used 3–4 quantitative metrics: annual blood collection volume per hospital bed, needle consumption per 1,000 diagnostic tests, syringe units per vaccination campaign, and safety-device conversion rates.
Segmented demand by product type (needles, syringes), vein type (cephalic, median cubital, basilic, others), and end-user (hospitals, diagnostic laboratories, blood donation camps).
Data Accuracy & Quality Check
Guaranteed 85–90% estimated data accuracy through cross-validation of primary interview transcripts with secondary trade statistics.
Implemented multi-level data triangulation across regional markets, product segments, and end-user verticals.
Every report is updated to the date of purchase, ensuring recency of market projections and competitive intelligence.
Saudi Arabia
UAE
South Africa
Egypt
Israel
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
11.1.9.2. Products
11.1.9.3. Company Financials
11.1.9.4. SWOT Analysis
11.1.10. Vygon Group
11.1.10.1. Company Overview
11.1.10.2. Products
11.1.10.3. Company Financials
11.1.10.4. SWOT Analysis
11.1.11. Weigao Group Medical Polymer Co. Ltd.
11.1.11.1. Company Overview
11.1.11.2. Products
11.1.11.3. Company Financials
11.1.11.4. SWOT Analysis
11.1.12. Hindustan Syringes & Medical Devices Ltd.
11.1.12.1. Company Overview
11.1.12.2. Products
11.1.12.3. Company Financials
11.1.12.4. SWOT Analysis
11.1.13. Retractable Technologies Inc.
11.1.13.1. Company Overview
11.1.13.2. Products
11.1.13.3. Company Financials
11.1.13.4. SWOT Analysis
11.1.14. EXELINT International
11.1.14.1. Company Overview
11.1.14.2. Products
11.1.14.3. Company Financials
11.1.14.4. SWOT Analysis
11.1.15. Jiangsu Jichun Medical Devices Co. Ltd.
11.1.15.1. Company Overview
11.1.15.2. Products
11.1.15.3. Company Financials
11.1.15.4. SWOT Analysis
11.1.16. Narang Medical Limited
11.1.16.1. Company Overview
11.1.16.2. Products
11.1.16.3. Company Financials
11.1.16.4. SWOT Analysis
11.1.17. Vitromed Healthcare
11.1.17.1. Company Overview
11.1.17.2. Products
11.1.17.3. Company Financials
11.1.17.4. SWOT Analysis
11.1.18. SungShim Medical Co. Ltd.
11.1.18.1. Company Overview
11.1.18.2. Products
11.1.18.3. Company Financials
11.1.18.4. SWOT Analysis
11.1.19. CML Biotech
11.1.19.1. Company Overview
11.1.19.2. Products
11.1.19.3. Company Financials
11.1.19.4. SWOT Analysis
11.1.20. Demophorius Healthcare
11.1.20.1. Company Overview
11.1.20.2. Products
11.1.20.3. Company Financials
11.1.20.4. SWOT Analysis
11.1.21. FL MEDICAL s.r.l.
11.1.21.1. Company Overview
11.1.21.2. Products
11.1.21.3. Company Financials
11.1.21.4. SWOT Analysis
11.1.22. Improve Medical
11.1.22.1. Company Overview
11.1.22.2. Products
11.1.22.3. Company Financials
11.1.22.4. SWOT Analysis
11.2. Market Entropy
11.2.1. Company's Key Areas Served
11.2.2. Recent Developments
11.3. Company Market Share Analysis, 2026
11.3.1. Top 5 Companies Market Share Analysis
11.3.2. Top 3 Companies Market Share Analysis
11.4. List of Potential Customers
Figure 16: Europe Venipuncture Needles and Syringes Market Revenue (Billion), by Country 2026 & 2034
Figure 17: Europe Venipuncture Needles and Syringes Market Revenue Share (%), by Country 2026 & 2034
Figure 18: Asia-Pacific Venipuncture Needles and Syringes Market Revenue (Billion), by Product 2026 & 2034
Figure 19: Asia-Pacific Venipuncture Needles and Syringes Market Revenue Share (%), by Product 2026 & 2034
Figure 20: Asia-Pacific Venipuncture Needles and Syringes Market Revenue (Billion), by Vein Type 2026 & 2034
Figure 21: Asia-Pacific Venipuncture Needles and Syringes Market Revenue Share (%), by Vein Type 2026 & 2034
Figure 22: Asia-Pacific Venipuncture Needles and Syringes Market Revenue (Billion), by End-User 2026 & 2034
Figure 23: Asia-Pacific Venipuncture Needles and Syringes Market Revenue Share (%), by End-User 2026 & 2034
Figure 24: Asia-Pacific Venipuncture Needles and Syringes Market Revenue (Billion), by Country 2026 & 2034
Figure 25: Asia-Pacific Venipuncture Needles and Syringes Market Revenue Share (%), by Country 2026 & 2034
Figure 26: Middle East and Africa Venipuncture Needles and Syringes Market Revenue (Billion), by Product 2026 & 2034
Figure 27: Middle East and Africa Venipuncture Needles and Syringes Market Revenue Share (%), by Product 2026 & 2034
Figure 28: Middle East and Africa Venipuncture Needles and Syringes Market Revenue (Billion), by Vein Type 2026 & 2034
Figure 29: Middle East and Africa Venipuncture Needles and Syringes Market Revenue Share (%), by Vein Type 2026 & 2034
Figure 30: Middle East and Africa Venipuncture Needles and Syringes Market Revenue (Billion), by End-User 2026 & 2034
Figure 31: Middle East and Africa Venipuncture Needles and Syringes Market Revenue Share (%), by End-User 2026 & 2034
Figure 32: Middle East and Africa Venipuncture Needles and Syringes Market Revenue (Billion), by Country 2026 & 2034
Figure 33: Middle East and Africa Venipuncture Needles and Syringes Market Revenue Share (%), by Country 2026 & 2034
Figure 34: South America Venipuncture Needles and Syringes Market Revenue (Billion), by Product 2026 & 2034
Figure 35: South America Venipuncture Needles and Syringes Market Revenue Share (%), by Product 2026 & 2034
Figure 36: South America Venipuncture Needles and Syringes Market Revenue (Billion), by Vein Type 2026 & 2034
Figure 37: South America Venipuncture Needles and Syringes Market Revenue Share (%), by Vein Type 2026 & 2034
Figure 38: South America Venipuncture Needles and Syringes Market Revenue (Billion), by End-User 2026 & 2034
Figure 39: South America Venipuncture Needles and Syringes Market Revenue Share (%), by End-User 2026 & 2034
Figure 40: South America Venipuncture Needles and Syringes Market Revenue (Billion), by Country 2026 & 2034
Figure 41: South America Venipuncture Needles and Syringes Market Revenue Share (%), by Country 2026 & 2034
Table 16: Germany Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 17: France Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 18: UK Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 19: Italy Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 20: Spain Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 21: Netherlands Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 22: Switzerland Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 23: Belgium Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 24: Russia Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 25: Turkey Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 26: Rest of Europe Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 27: Asia-Pacific Venipuncture Needles and Syringes Market Revenue Billion Forecast, by Product 2020 & 2034
Table 28: Asia-Pacific Venipuncture Needles and Syringes Market Revenue Billion Forecast, by Vein Type 2020 & 2034
Table 29: Asia-Pacific Venipuncture Needles and Syringes Market Revenue Billion Forecast, by End-User 2020 & 2034
Table 30: Asia-Pacific Venipuncture Needles and Syringes Market Revenue Billion Forecast, by Country 2020 & 2034
Table 31: China Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 32: Japan Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 33: India Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 34: South Korea Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 35: Singapore Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 36: Malaysia Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 37: Australia Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 38: Thailand Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 39: Indonesia Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 40: Philippines Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 41: Rest of Asia-Pacific Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 42: Middle East and Africa Venipuncture Needles and Syringes Market Revenue Billion Forecast, by Product 2020 & 2034
Table 43: Middle East and Africa Venipuncture Needles and Syringes Market Revenue Billion Forecast, by Vein Type 2020 & 2034
Table 44: Middle East and Africa Venipuncture Needles and Syringes Market Revenue Billion Forecast, by End-User 2020 & 2034
Table 45: Middle East and Africa Venipuncture Needles and Syringes Market Revenue Billion Forecast, by Country 2020 & 2034
Table 46: Saudi Arabia Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 47: UAE Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 48: South Africa Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 49: Egypt Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 50: Israel Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 51: Rest of Middle East and Africa Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 52: South America Venipuncture Needles and Syringes Market Revenue Billion Forecast, by Product 2020 & 2034
Table 53: South America Venipuncture Needles and Syringes Market Revenue Billion Forecast, by Vein Type 2020 & 2034
Table 54: South America Venipuncture Needles and Syringes Market Revenue Billion Forecast, by End-User 2020 & 2034
Table 55: South America Venipuncture Needles and Syringes Market Revenue Billion Forecast, by Country 2020 & 2034
Table 56: Brazil Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 57: Argentina Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 58: Rest of South America Venipuncture Needles and Syringes Market Revenue (Billion) Forecast, by Application 2020 & 2034
Venipuncture Needles and Syringes Market.jpg){kind=small}
